SimonM, BourelM, FauchetR, GenetetB.Association of HLA-A3 and HLA-B14 antigens with idiopathic haemochromatosis. Gut1976;17:332–4.
2.
SimonM, BourelM, GenetetB, FauchetR.Idiopathic hemochromatosis. Demonstration of recessive transmission and early detection by family HLA typing. N Engl J Med1977;297:1017–21.
3.
FederJN, GnirkeA, ThomasW, TsuchihashiZ, RuddyDA, BasavaA, DormishianF, DomingoRJr, EllisMC, FullanA, HintonLM, JonesNL, KimmelBE, KronmalGS, LauerP, LeeVK, LoebDB, MapaFA, McClellandE, MeyerNC, MintierGA, MoellerN, MooreT, MorikangE, PrassCE, QuintanaL, StarnesSM, SchatzmanRC, BrunkeKJ, DraynaDT, RischNJ, BaconBR, WolffRR. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet1996;13:399–408.
4.
de SilvaDM, AskwithCC, KaplanJ.Molecular mechanisms of iron uptake in eukaryotes. Physiol Rev1996;76:31–47.
5.
BrittonRS, BaconBR, RecknagelRO. Lipid peroxidation and associated hepatic organelle dysfunction in iron overload. Chem Phys Lipids1987;45:207–39.
6.
BothwellTH. Overview and mechanisms of iron regulation. Nutr Rev1995;53:237–45.
7.
GunshinH, MackenzieB, BergerUV, GunshinY, RomeroMF, BoronWF, NussbergerS, GollanJL, HedigerMA. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature1997;388:482–8.
8.
PowellLW, CampbellCB, WilsonE.Intestinal mucosal uptake of iron and iron retention in idiopathic haemochromatosis as evidence for a mucosal abnormality. Gut1970;11:727–31.
9.
McLarenGD, NathansonMH, JacobsA, Trevett-DT, ThomsonW.Regulation of intestinal iron absorption and mucosal iron kinetics in hereditary hemochromatosis. J Lab Clin Med1991;117:390–401.
10.
PietrangeloA, RocchiE, CasalgrandiG, RigoG, FerrariA, PeriniM, VenturaE, CairoG.Regulation of Transferrin, Transferrin Receptor, and Ferritin Genes in Human Duodenum. Gastroenterology1992;102:802–9.
11.
QianZM, TangPL. Mechanisms of iron uptake by mammalian cells. Biochem Biophys Acta1995;1269:205–14.
12.
MorganEH, SmithGD, PetersTJ. Uptake and subcellular processing of 59Fe-125Ilabelled transferrin by rat liver. Biochem J1986;237:163–73.
13.
OsterlohK, AisenP.Pathways in the binding and uptake of ferritin by hepatocytes. Biochim Biophys Acta1989;1011:40–5.
14.
SciotR, PatersonAC, Van den OordJJ, DesmetVJ. Lack of hepatic transferrin receptor expression in hemochromatosis. Hepatology1987:7:831–7.
15.
LombardM, BomfordA, HynesM, NaoumovNV, RobertsS, CroweJ, WilliamsR.Regulation of the hepatic transferrin receptor in hereditary hemochromatosis. Hepatology1989;9:1–5.
16.
PietrangeloA, RocchiE, CasalgrandiG, RigoG, FerrariA, PeriniM, VenturaE, CairoG.Regulation of transferrin, transferrin receptor, and ferritin genes in human duodenum. Gastroenterology1992;102:802–9.
17.
GirelliD, OlivieriO, De FranceschiL, CorrocherR, BergamaschiG, CazzolaM.A linkage between hereditary hyperferritinaemia not related to iron overload and autosomal dominant congenital cataract. Br J Haematol1995;90:931–4.
18.
GirelliD, CorrocherR, BiscegliaL, OlivieriO, De FranceschiL, ZelanteL, GaspariniP.Molecular basis for the recently described hereditary hyperferritinemiacataract syndrome: a mutation in the iron-responsive element of ferritin L-subunit gene (the “Verona mutation”). Blood1995;86:4050–3.
19.
Aguilar-MartinezP, BironC, MasmejeanC, JeanjeanP, SchvedJF. A novel mutation in the iron responsive element of ferritin L-subunit gene as a cause for hereditary hyperferritinemia-cataract syndrome [letter]. Blood1996;88:1895.
20.
HentzeMW, KuhnLC. Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. Proc Natl Acad Sci U S A1996;93:8175–82.
21.
HarrisonPM, ArosioP.The ferritins: molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta1996;1275:161–203.
22.
LipschitzDA, CookJD, FinchCA. A clinical evaluation of serum ferritin as an index of iron stores. N Engl J Med1974;290:1213–6.
23.
FlanaganPR, HajduA, AdamsPC. Iron-responsive element-binding protein in hemochromatosis liver and intestine. Hepatology1995;22:828–32.
24.
JazwinskaEC, LeeSC, WebbSI, HallidayJW, PowellLW. Localization of the hemochromatosis gene close to D6S105. Am J Hum Genet1993;53:347–52.
25.
GaspariniP, BorgatoL, PipernoA, GirelliD, OlivieriO, GottardiE, RoettoA, DianzaniI, FargionS, SchinaiaG, Linkage analysis of 6p21 polymorphic markers and the hereditary hemochromatosis: localization of the gene centromeric to HLA-F. Hum Mol Genet1993;2:571–6.
26.
JazwinskaEC, PyperWR, BurtMJ, FrancisJL, GoldwurmS, WebbSI, LeeSC, HallidayJW, PowellLW. Haplotype analysis in Australian hemochromatosis patients: evidence for a predominant ancestral haplotype exclusively associated with hemochromatosis. Am J Hum Genet1995;56:428–33.
27.
Raha-ChowdhuryR, BowenDJ, StoneC, PointonJJ, TerwilligerJD, ShearmanJD, RobsonKJ, BomfordA, WorwoodM.New polymorphic microsatellite markers place the haemochromatosis gene telomeric to D6S105. Hum Mol Genet1995;4:1869–74.
28.
AjiokaRS, JordeLB, GruenJR, YuP, DimitrovaD, BarrowJ, RadiskyE, EdwardsCQ, GriffenLM, KushnerJP. Haplotype analysis of hemochromatosis: evaluation of different linkage-disequilibrium approaches and evolution of disease chromosomes. Am J Hum Genet1997;60:1439–47.
29.
BurmeisterWP, GastineiLN, SimisterNE, BlumML, BjorkmanPJ. Crystal structure at 2.Å resolution of the MHC-related neonatal Fc receptor. Nature1994;372:336–43.
30.
ChorneyMJ, SawadaI, GillespieGA, SrivastavaR, PanJ, WeissmanSM. Transcription analysis, physical mapping, and molecular characterization of a nonclassical human leukocyte antigen class I gene. Mol Cell Biol1990;10:243–53.
31.
ShaheenNJ, BaconBR, GrimmIS. Clinical characteristics of patients diagnosed with hereditary hemochromatosis who lack the Cys282Tyr mutation [abstract]. Gastroenterology1997;112:A1381.
CarellaM, D'AmbrosioL, TotaroA, GrifaA, ValentinoMA, PipernoA, GirelliAR, FrancoB, GaspariniP, CamaschellaC.Mutation analysis of the HLA- H gene in Italian hemochromatosis patients. Am J Hum Genet1997;60:828–32.
36.
Merryweather-ClarkeAT, PointonJJ, ShearmanJD. RobsonK.J. H. Global prevalence of putative hemochromatosis mutations1997;34:275–8.
37.
RothMP, GiraldoP, HaritiG, PoloniES, SanchezmazasA, DestefanoGF, DugoujonJM, CoppinH.Absence of the hemochromatosis gene Cys282Tyr mutation in three ethnic groups from Algeria (MZAB), Ethiopia, and Senegal. Immunogenetics1997;46:222–5.
38.
MiyazakiJ, AppellaE, OzatoK.Intracellular transport blockade caused by disruption of the disulfide bridge in the third external domain of major histocompatibility complex class I antigen. Proc Natl Acad Sci U S A1986;83:757–61.
39.
FederJN, TsuchihashiZ, IrrinkiA, LeeVK, MapaFA, MorikangE, PrassCE, StarnesSM, WolffRK, ParkkilaS, SlyWS, SchatzmanRC. The hemochromatosis founder mutation in HLA-H disrupts ß2-microglobulin interaction and cell surface expression. J Biol Chem1997;272:14025–8.
40.
ParkkilaS, WaheedA, BrittinRS, FederJN, TsuchihashiZ, SchatzmanRC, BaconBR, SlyWS. Immunohistochemistry of HLA-H, the protein defective in patients with hereditary hemochromatosis, reveals unique pattern of expression in gastrointestinal tract. Proc Natl Acad Sci U SA1997;94:2534–9.
41.
SimonM, BrissotP.The genetics of haemochromatosis. J Hepatol1988;6:116–24.
42.
RotterJI, DiamondJM. What maintains the frequencies of human genetic diseases?Nature1987Sep24-30;329:289–90.
43.
LittleP.Human genetics. Woman's meat, a man's poison. Nature1996;382:494–5.
44.
IancuTC. Animal models in liver research: iron overload. Adv Vet Sci Comp Med1993;37:379–401.
45.
de SousaM, ReimaoR, LacerdaR, HugoP, KaufmannSH, PortoG.Iron overload in ß2-microglobulin-deficient mice. Immunol Lett1994;39:105–11.
46.
RothenbergBE, VolandJR. B2 knockout mice develop parenchymal iron overload: A putative role for class I genes of the major histocompatibility complex in iron metabolism. Proc Natl Acad Sci U S A1996;93:1529–34.
47.
SantosM, SchilhamMW, RademakersLHPM, MarxJJM, de SousaM, CleversH.Defective iron homeostasis in β2-microglobulin knockout mice recapitulates hereditary hemochromatosis in man. J Exp Med1996;184:1975–85.
48.
BassettML, HallidayJW, PowellLW. Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology1986;6:24–9.
49.
AdamsPC, DeugnierY, MoirandR, BrissotP.The relationship between iron overload, clinical symptoms and age in 410 patients with genetic hemochromatosis. Hepatology1997;25:162–6.
50.
PipernoA, FargionS, D'AlbaR, RoffiL, FracanzaniAL, VecchiL, FaillaM, FiorelliG.Liver damage in Italian patients with hereditary hemochromatosis is highly influenced by hepatitis B and C virus infection. J Hepatol1992;16:364–8.
51.
LorealO, DeugnierY, MoirandR, LauvinL, GuyaderD, JouanolleH, TurlinB, LescoatG, BrissotP.Liver fibrosis in genetic hemochromatosis. Respective roles of iron and non-iron-related factors in 127 homozygous patients. J Hepatol1992;16:122–7.
52.
SummersKM, HallidayJW, PowellLW. Identification of homozygous hemochromatosis subjects by measurement of hepatic iron index. Hepatology1990;12:20–5.
53.
NiederauC, FischerR, PurschelA, StremmelW, HaussingerD, StrohmeyerG.Long-term survival in patients with hereditary hemochromatosis. Gastroenterology1996;110:1107–19.
54.
MandelliC, CesariniL, PipernoA, FargionS, FracanzaniAL, BarisaniD, ConteD.Saturability of hepatic iron deposits in genetic hemochromatosis. Hepatology1992;16:956–9.
EdwardsCQ, KellyTM, EllweinG, KushnerJP. Thyroid disease in hemochromatosis. Increased incidence in homozygous men. Arch Intern Med1983;143:1890–3.
61.
KellyTM, EdwardsCQ, MeikleAW, KushnerJP. Hypogonadism in hemochromatosis: reversal with iron depletion. Ann Intern Med1984;101:629–32.
62.
SiminoskiK, D'CostaM, WalfishPG. Hypogonadotropic hypogonadism in idiopathic hemochromatosis: evidence for combined hypothalamic and pituitary involvement. J Endocrinol Invest1990;13:849–53.
63.
de SèzeS, SolnicaJ, MitrovicD, MiravetL, DorfmanH.Joint and bone disorders and hypoparathyroidism in hemochromatosis. Semin Arth Rheum1972;2:71–94.
64.
HamiltonEB, BomfordAB, LawsJW, WilliamsR.The natural history of arthritis in idiopathic haemochromatosis; progression of the clinical and radiological features over ten years. Q J Med1981;50:321–9.
RobertsAG, WhatleySD, MorganRR, WorwoodM, ElderGH. Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda. Lancet1997;349:321–3.
67.
KushnerJP, EdwardsCQ, DadoneMM, SkolnickMH. Heterozygosity for HLA- linked hemochromatosis as a likely cause of the hepatic siderosis associated with sporadic porphyria cutanea tarda. Gastroenterology1985;88:1232–8.
68.
DadoneMM, KushnerJP, EdwardsCQ, BishopDT, SkolnickMH. Hereditary hemochromatosis. Analysis of laboratory expression of the disease by genotype in 18 pedigrees. Am J Clin Pathol1982;78:196–207.
69.
BulajZJ, GriffinLM, JordeLB, EdwardsCQ, KushnerJP. Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. N Engl J Med1996;335:1799–805.
70.
BassettML, HallidayJW, FerrisRA, PowellLW. Diagnosis of hemochromatosis in young subjects: predictive accuracy of biochemical screening tests. Gastroenterology1984;87:628–33.
71.
BeaumontC, SimonM, FauchetR, HespelJP, BrissotP, GenetetB, BourelM.Serum ferritin as a possible marker of the hemochromatosis allele. N Engl J Med1979;301:169–74.
72.
WandsJR, RoweJA, MezeySE, WaterburyLA, WrightJR, HallidayJW, IsselbacherKJ, PowellLW. Normal serum ferritin concentrations in precirrhotic hemochromatosis. N Engl J Med1976;294:302–5.
73.
HerbertV, JayatillekeE, ShawS, RosmanAS, GiardinaP, GradyRW, BowmanB, GunterEW. Serum ferritin iron, a new test, measures human body iron stores unconfounded by inflammation. Stem Cells1997;15:291–6.
74.
MoirandR, MortajiAM, LoréalO, PaillardF, BrissotP, DeugnierY.A new syndrome of liver iron overload with normal transferrin saturation. Lancet1997;349:95–7.
75.
BrinkB, DislerP, LynchS, JacobsP, CharltonR, BothwellT.Patterns of iron storage in dietary iron overload and idiopathic hemochromatosis. J Lab Clin Med1976;88:725–31.
76.
BlitzerBL, WeissGB, OsbaldistonGW, MarkhamRB, AamodtR, BerkPD, WolffSM, FauciAS. Early idiopathic hemochromatosis with absent stainable bone marrow iron stores. Gastroenterology1978;75:886–8.
77.
SallieRW, ReedWD, ShilkinKB. Confirmation of the efficacy of hepatic tissue iron index in differentiating genetic haemochromatosis from alcoholic liver disease complicated by alcoholic haemosiderosis. Gut1991;32:207–10.
78.
PowellLW, SummersKM, BoardPG, AxelsenE, WebbS, HallidayJW. Expression of hemochromatosis in homozygous subjects. Implications for early diagnosis and prevention. Gastroenterology1990;98:1625–32.
79.
MandelliC, CesariniL, PipernoA, FargionS, FracanzaniAL, BarisaniD, ConteD.Saturability of hepatic iron deposits in genetic hemochromatosis. Hepatology1992;16:956–9.
80.
LudwigJ, HashimotoE, PoraykoMK, MoyerTP, BaldusWP. Hemosiderosis in cirrhosis: a study of 447 native livers. Gastroenterology1997;112:882–8.
81.
EdwardsCQ, CartwrightGE, SkolnickMH, AmosDB. Homozygosity for hemochromatosis: clinical manifestations. Ann Intern Med1980;93:519–25.
82.
BernsteinSE. Hereditary hypotransferrinemia with hemosiderosis, a murine disorder resembling human atransferrinemia. J Lab Clin Med1987;110:690–705.
83.
YoshidaK, FurihataK, TakedaS, NakamuraA, YamamotoK, MoritaH, HiyamutaS, IkedaS, ShimizuN, YanagisawaN.A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans. Nat Genet1995;9:267–72.
84.
HarrisZL, TakahashiY, MiyajimaH, SerizawaM, MacGiIlvrayRTA, GitlinJD. Aceruloplasminemia: Molecular characterization of this disorder of iron metabolism. Proc Natl Acad Sci U S A1995;92:2539–43.
85.
GordeukV, MukiibiJ, HasstedtSJ, SamowitzW, EdwardsCQ, WestG, NdambireS, EmmanualJ, NkanzaN, ChapandukaZ, RandallM, BooneP, RomanoP, MartellRW, YamashitaT, EfflerP, BrittenhamG.Iron overload in Africa: Interaction between a gene and dietary iron content. N Engl J Med1992;326:95–100.
86.
EasonRJ, AstonCE, AdamsPC, SearleI.Familial iron overload with possible autosomal dominant inheritance. Aust NZ J Med1990;20:226–30.
87.
BonkovskyHL, BannerBF, LambrechtRW, RubinRB. Iron in liver diseases other than hemochromatosis. Semin Liver Dis1996;16:65–82.
88.
WurapaRK, GordeukVR, BrittenhamGM, KhiyamiA, SchechterGP, EdwardsCQ. Primary iron overload in African Americans. Am J Med1996;101:9–18.
89.
PerkinsKW, McInnesIWS, BlackburnCRB, BealRW. Idiopathic haemochromatosis in children. Report of a family. Am J Med1965;39:118–26.
90.
CharltonRW, AbrahamsC, BothwellTH. Idiopathic hemochromatosis in young subjects. Clinical, pathological, and chemical findings in four patients. Arch PathoI1967;83:132–40.
91.
MenahemS, SalmonAP, DennettX.Haemochromatosis presenting as severe cardiac failure in a young adolescent. Int J CardioI1990;29:86–9.
92.
HaddyTB, CastroOL, RanaSR. Hereditary hemochromatosis in children, adolescents, and young adults. Am J Pediatr Hematol Oncol1988;10:23–34.
93.
AdamsPC, KerteszAE, ValbergLS. Rate of iron reaccumulation following iron depletion in hereditary hemochromatosis. Implications for venesection therapy. J Clin GastroenteroI1993;16:207–10.
94.
AgroyannisB, KoutsicosD, Tzanatou-ExarchouH, Varsou PapadimitriouE, KapetanakiA, YatzidisH.Combined recombinant human erythropoietin-blood letting strategy for treating anemia and iron overload in hemodialysis patients. Int J Artif Organs1991;14:403–6.
95.
FracanzaniAL, FargionS, RomanoR, ConteD, PipernoA, D' AlbaR, MandelliC, FraquelliM, PacchettiS, BragaM, FiorelliG.Portal hypertension and iron depletion in patients with genetic hemochromatosis. Hepatology1995;22:1127–31.
96.
Candell-RieraJ, LuL, SeresL, GonzalezJB, BatlleJ, Permanyer MiraldaG, Garcia-del-CastilloH, Soler-SolerJ.Cardiac hemochromatosis: beneficial effects of iron removal therapy. An echocardiographic study. Am J Cardio11983;52:824–9.
97.
DabestaniA, ChildJS, HenzeE, PerloffJK, SchonH, FigueroaWG, Sche1bertHR, ThessomboonS.Primary hemochromatosis: anatomic and physiologic characteristics of the cardiac ventricles and their response to phlebotomy. Am J Cardiol1984;54:153–9.
98.
CundyT, ButlerJ, BomfordA, WilliamsR.Reversibility of hypog onadotrophic hypogonadism associated with genetic haemochromatosis. Clin Endocrino1 (Oxt)1993;38:617–20.
99.
CrawfordDH, HallidayJW, SummersKM, BourkeMJ, PowellLW. Concordance of iron storage in siblings with genetic hemochromatosis: evidence for a predominantly genetic effect on iron storage. Hepatology1993;17:833–7.
100.
AskariAD, MuirWA, RosnerlA, MoskowitzRW, McLarenGD, BraunWE. Arthritis of hemochromatosis. Clinical spectrum, relation to histocompatibility antigens, and effectiveness of early phlebotomy. Am J Med1983;75:957–65.
101.
SemposCT, LookerAC, GillumRF, MakucDM. Body iron stores and the risk of coronary heart disease. N Engl J Med1994;330:1119–24.
102.
AmmannRW, MullerE, BanskyJ, SchulerG, HackiWH. High incidence of extrahepatic carcinomas in idiopathic hemochromatosis. Scand J GastroenteroI1980;15:733–6.
103.
HsingAW, McLaughlinJK, OlsenJH, MellemkjarL, WacholderS, FraumeniJFJr.. Cancer risk following primary hemochromatosis: a population-based cohort study in Denmark. Int J Cancer1995;60:160–2.
104.
StevensRG, JonesDY, MicozziMS, TaylorPR. oBody iron stores and the risk of cancer. N Engl J Med1988;319:1047–52.
105.
HerrintonU, FriedmanGD, BaerD, SelbyJV. Transferrin saturation and risk of cancer. Am J EpidemioI1995;142:692–8.
106.
KilpeVE, KrakauerH, WrenH.E. An analysis of liver transplant experience from 37 transplant centers as reported to Medicare. Transplantation1993;56:554–61.
107.
GraceND. Liver transplantation for hemochromatosis: an ironic dilemma. Liver Transplant Surg1995;1:234–6.
108.
KowdleyKV, HassanienT, KaurS, FarrellFJ, Van TheilDH, KeefeEB, SorrellMF, BaconB. R., WebberFLJr, TavillAS. Primary liver cancer and survival in patients undergoing transplantation for hemochromatosis. Liver Transplant Surg1995;1:237–41.
109.
PillayP, TzoracoleftherakisE, TzakisAG, KakizoeS, Van ThielDH, StarzlTE. Orthotopic liver transplantation for hemochromatosis. Transplant Proc1991;23:1888–9.
110.
AdamsPC, GhentCN, GrantDR, FreiJV, WallWJ. Transplantation of a donor liver with haemochromatosis: evidence against an inherited intrahepatic defect. Gut1991;32:1082–3.
111.
DabkowskiPL, AngusPW, SmallwoodRA, IretonJ, JonesRM. Site of principal metabolic defect in idiopathic haemochromatosis: insights from transplantation of an affected organ. Br Med J1993;306:1726.
112.
KoskinasJ, PortmannB, LombardM, SmithT, WilliamsR.Persistent iron overload 4 years after inadvertent transplantation of a haemochromatotic liver in a patient with primary biliary cirrhosis. J HepatoI1992;16:351–4.
113.
FarrellFJ, NguyenM, WoodleyS, ImperialJC, Garcia-KennedyR, ManK, EsquivelCO, KeeffeEB. Outcome of liver transplantation in patients with hemochromatosis. Hepatology1994;20:404–10.
114.
OlivieriNF, BrittenhamGM. Iron-chelating therapy and the treatment of thalassemia. Blood1997;89:739–61.
115.
SchaferAI, CheronRG, D1uhyR, CooperB, GleasonRE, SoeldnerJS, BunnHF. Clinical consequences of acquired transfusional iron overload in adults. N Engl J Med1981;304:319–24.
116.
PhatakPD, GuzmanG, WollJE, RobesonA, PhelpsCE.o Cost effectiveness of screening for hereditary hemochromatosis. Arch Intern Med1994;154:769–76.
117.
BuffoneGJ, BeckJR. Cost-effectiveness analysis for evaluation of screening programs: hereditary hemochromatosis. Clin Chern1994;40:1631–6.
118.
AdamsPC, GregorJC, KerteszAE, ValbergLS. Screening blood donors for hereditary hemochromatosis: decision analysis model based on a 30-year database. Gastroenterology1995;109:177–88.
119.
BaerDM, SimonsJL, StaplesRL, RumoreGJ, MortonCJ. Hemochromatosis screening in asymptomatic ambulatory men 30 years of age and older. Am J Med1995;98:464–8.